Home Cart Sign in  
Chemical Structure| 29883-15-6 Chemical Structure| 29883-15-6

Structure of Amygdalin
CAS No.: 29883-15-6

Chemical Structure| 29883-15-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Amygdalin is a glycoside initially isolated from the seeds of the tree Prunus dulcis, also known as bitter almonds.

Synonyms: Amygdaloside; NSC 15780; (R)-Amygdalin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Amygdalin

CAS No. :29883-15-6
Formula : C20H27NO11
M.W : 457.43
SMILES Code : N#C[C@H](O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO)O2)O)O)O)O1)O)O)O)C3=CC=CC=C3
Synonyms :
Amygdaloside; NSC 15780; (R)-Amygdalin
MDL No. :MFCD00006598

Safety of Amygdalin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
LNCaP cells 10 mg/mL 24 h To evaluate the inhibitory effect of amygdalin combined with β-glucosidase on LNCaP cells. Results showed that the combination significantly reduced the IC50 value, indicating that β-glucosidase enhanced the cytotoxicity of amygdalin. Int J Nanomedicine. 2020 Jun 29;15:4639-4657
PC3 cells 10 mg/mL 24 h To evaluate the inhibitory effect of amygdalin combined with β-glucosidase on PC3 cells. Results showed that the combination significantly reduced the IC50 value, indicating that β-glucosidase enhanced the cytotoxicity of amygdalin. Int J Nanomedicine. 2020 Jun 29;15:4639-4657
RM1 cells 10 mg/mL 24 h To evaluate the inhibitory effect of amygdalin combined with β-glucosidase on RM1 cells. Results showed that the combination significantly reduced the IC50 value, indicating that β-glucosidase enhanced the cytotoxicity of amygdalin. Int J Nanomedicine. 2020 Jun 29;15:4639-4657
Mouse skeletal muscle C2C12 cells 0-25 μM 24 or 48 h Induction of follistatin mRNA expression and stimulation of cell growth Chin Med. 2014 Sep 16;9:23
RAW 264.7 cells 5-40 µM 5 days Investigate the inhibitory effect of amygdalin on RANKL-induced osteoclast differentiation. Results showed that amygdalin inhibited TRAP activity and osteoclast differentiation in a concentration-dependent manner. Biomolecules. 2022 Feb 4;12(2):256

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice CCl4-induced liver fibrosis model Oral gavage 100 mg/kg Daily administration for 3 weeks To evaluate the therapeutic effect of amygdalin on liver fibrosis. Results showed amygdalin effectively ameliorated CCl4-induced liver fibrosis, reduced collagen deposition and α-SMA expression, and decreased serum ALT and AST levels. Drug Des Devel Ther. 2025 May 7;19:3735-3749

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.19mL

0.44mL

0.22mL

10.93mL

2.19mL

1.09mL

21.86mL

4.37mL

2.19mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories